Kinins are generated during experimental rhinovirus colds. 1988

R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
Department of Medicine, Johns Hopkins University, Baltimore, Maryland.

We investigated the pathophysiology of rhinovirus colds by challenging volunteers with either of two strains of rhinovirus or with placebo. Nasal lavages were done before challenge and every 4 h for five days after challenge. We measured the levels of histamine, kinins, [3H]-N-alpha-p-tosyl-L-arginine methyl ester (TAME)-esterase activity, and albumin and counted the number of neutrophils in the recovered lavage fluid. Subjects who became both infected and symptomatic showed increases in levels of kinins (P less than .03), TAME-esterase activity (P less than .04), and albumin (P less than .05), as well as in the number of neutrophils (P less than .01). The total number of symptoms reported correlated significantly with the net increase in the concentration of kinins (r = .549; P less than .01), albumin (r = .674; P less than .001), TAME-esterase activity (r = .563; P less than .005), and neutrophils (r = .605; P less than .005). Levels of histamine did not change during the course of infection. During symptomatic rhinovirus infections (1) kinins are generated, (2) vascular permeability increases, (3) basophils and mast cells do not participate, and (4) neutrophils enter nasal secretions.

UI MeSH Term Description Entries
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D009296 Nasal Cavity The proximal portion of the respiratory passages on either side of the NASAL SEPTUM. Nasal cavities, extending from the nares to the NASOPHARYNX, are lined with ciliated NASAL MUCOSA. Nasal Cavities,Cavities, Nasal,Cavity, Nasal
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D001826 Body Fluids Liquid components of living organisms. Body Fluid,Fluid, Body,Fluids, Body
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D003139 Common Cold A catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. It generally involves a runny nose, nasal congestion, and sneezing. Cold, Common,Coryza, Acute,Catarrh,Acute Coryza,Catarrhs,Colds, Common,Common Colds
D005260 Female Females

Related Publications

R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
January 1989, Bulletin of the New York Academy of Medicine,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
October 1994, American journal of respiratory and critical care medicine,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
September 1992, The Journal of allergy and clinical immunology,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
October 1985, British medical bulletin,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
May 1994, The Journal of infectious diseases,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
May 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
July 1988, Antiviral research,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
January 1995, International archives of allergy and immunology,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
January 1987, The American review of respiratory disease,
R M Naclerio, and D Proud, and L M Lichtenstein, and A Kagey-Sobotka, and J O Hendley, and J Sorrentino, and J M Gwaltney
June 2000, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!